Skip to main content
Top
Published in: Annals of Hematology 5/2012

01-05-2012 | Original Article

A prospective survey of febrile events in hematological malignancies

Authors: L. Pagano, M. Caira, G. Rossi, M. Tumbarello, R. Fanci, M. G. Garzia, N. Vianelli, N. Filardi, P. De Fabritiis, A. Beltrame, M. Musso, A. Piccin, A. Cuneo, C. Cattaneo, T. Aloisi, M. Riva, G. Rossi, U. Salvadori, M. Brugiatelli, S. Sannicolò, M. Morselli, A. Bonini, P. Viale, A. Nosari, F. Aversa, for the Hema e-Chart Group, Italy

Published in: Annals of Hematology | Issue 5/2012

Login to get access

Abstract

The Hema e-Chart prospectively collected data on febrile events (FEs) in hematological malignancy patients (HMs). The aim of the study was to assess the number, causes and outcome of HM-related FEs. Data were collected in a computerized registry that systematically approached the study and the evolution of FEs developing in a cohort of adult HMs who were admitted to 19 hematology departments in Italy from March 2007 to December 2008. A total of 869 FEs in 3,197 patients with newly diagnosed HMs were recorded. Fever of unidentified origin (FUO) was observed in 386 cases (44.4%). The other causes of FE were identified as noninfectious in 48 cases (5.5%) and infectious in 435 cases (50.1%). Bacteria were the most common cause of infectious FEs (301 cases), followed by fungi (95 cases), and viruses (7 cases). Mixed agents were isolated in 32 episodes. The attributable mortality rate was 6.7% (58 FEs). No deaths were observed in viral infection or in the noninfectious groups, while 25 deaths were due to FUO, 16 to bacterial infections, 14 to fungal infections, and three to mixed infections. The Hema e-Chart provided a complete system for the epidemiological study of infectious complications in HMs.
Literature
1.
go back to reference Faensen D, Claus H, Benzler J et al (2006) SurvNet@RKI—a multistate electronic reporting system for communicable diseases. Eur Surveill 11:100–103 Faensen D, Claus H, Benzler J et al (2006) SurvNet@RKI—a multistate electronic reporting system for communicable diseases. Eur Surveill 11:100–103
2.
go back to reference Guzman D, Veit D, Knerr V et al (2007) The ESID online database network. Bioinformatics 23:654–655PubMedCrossRef Guzman D, Veit D, Knerr V et al (2007) The ESID online database network. Bioinformatics 23:654–655PubMedCrossRef
3.
go back to reference Angelow A, Schmidt M, Weitmann K et al (2008) Methods and implementation of a central biosample and data management in a three-centre clinical study. Comput Methods Programs Biomed 91:82–90PubMedCrossRef Angelow A, Schmidt M, Weitmann K et al (2008) Methods and implementation of a central biosample and data management in a three-centre clinical study. Comput Methods Programs Biomed 91:82–90PubMedCrossRef
4.
go back to reference Pagano L, Caira M, Nosari A et al (2010) Hema e-Chart: Italian registry for prospective analysis of epidemiology, management and outcome of febrile events in patients with hematological malignancies. J Chemother 22:20–24PubMed Pagano L, Caira M, Nosari A et al (2010) Hema e-Chart: Italian registry for prospective analysis of epidemiology, management and outcome of febrile events in patients with hematological malignancies. J Chemother 22:20–24PubMed
5.
go back to reference Freifeld AG, Bow EJ, Sepkowitz KA et al (2011) Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis 52(4):e56–e93PubMedCrossRef Freifeld AG, Bow EJ, Sepkowitz KA et al (2011) Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis 52(4):e56–e93PubMedCrossRef
6.
go back to reference Hughes WT, Armstrong D, Bodey GP et al (2002) 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis 34:730–751PubMedCrossRef Hughes WT, Armstrong D, Bodey GP et al (2002) 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis 34:730–751PubMedCrossRef
7.
go back to reference De Pauw B, Walsh TJ, Donnelly JP et al (2008) Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 46:1813–1821PubMedCrossRef De Pauw B, Walsh TJ, Donnelly JP et al (2008) Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 46:1813–1821PubMedCrossRef
8.
go back to reference Wingard JR, Ribaud P, Schlamm HT, Herbrecht R (2008) Changes in causes of death over time after treatment for invasive aspergillosis. Cancer 112:2309–2312PubMedCrossRef Wingard JR, Ribaud P, Schlamm HT, Herbrecht R (2008) Changes in causes of death over time after treatment for invasive aspergillosis. Cancer 112:2309–2312PubMedCrossRef
9.
go back to reference Pagano L, Caira M, Candoni A et al (2006) The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study. Haematologica 91:1068–1075PubMed Pagano L, Caira M, Candoni A et al (2006) The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study. Haematologica 91:1068–1075PubMed
10.
go back to reference Pagano L, Caira M, Nosari A et al (2007) Fungal infections in recipients of hematopoietic stem cell transplants: results of the SEIFEM B-2004 study—Sorveglianza Epidemiologica Infezioni Fungine nelle Emopatie Maligne. Clin Infect Dis 45:1161–1170PubMedCrossRef Pagano L, Caira M, Nosari A et al (2007) Fungal infections in recipients of hematopoietic stem cell transplants: results of the SEIFEM B-2004 study—Sorveglianza Epidemiologica Infezioni Fungine nelle Emopatie Maligne. Clin Infect Dis 45:1161–1170PubMedCrossRef
11.
go back to reference Neofytos D, Horn D, Anaissie E et al (2009) Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry. Clin Infect Dis 48:265–273PubMedCrossRef Neofytos D, Horn D, Anaissie E et al (2009) Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry. Clin Infect Dis 48:265–273PubMedCrossRef
12.
go back to reference Hakim H, Flynn PM, Knapp KM, Srivastava DK, Gaur AH (2009) Etiology and clinical course of febrile neutropenia in children with cancer. J Pediatr Hematol Oncol 31:623–629PubMedCrossRef Hakim H, Flynn PM, Knapp KM, Srivastava DK, Gaur AH (2009) Etiology and clinical course of febrile neutropenia in children with cancer. J Pediatr Hematol Oncol 31:623–629PubMedCrossRef
13.
go back to reference Gupta A, Singh M, Singh H et al (2010) Infections in acute myeloid leukemia: an analysis of 382 febrile episodes. Med Oncol 27:1037–1045PubMedCrossRef Gupta A, Singh M, Singh H et al (2010) Infections in acute myeloid leukemia: an analysis of 382 febrile episodes. Med Oncol 27:1037–1045PubMedCrossRef
14.
go back to reference Dettenkofer M, Wenzler-Röttele S, Babikir R et al (2005) Surveillance of nosocomial sepsis and pneumonia in patients with a bone marrow or peripheral blood stem cell transplant: a multicenter project. Clin Infect Dis 40(7):926–931PubMedCrossRef Dettenkofer M, Wenzler-Röttele S, Babikir R et al (2005) Surveillance of nosocomial sepsis and pneumonia in patients with a bone marrow or peripheral blood stem cell transplant: a multicenter project. Clin Infect Dis 40(7):926–931PubMedCrossRef
15.
go back to reference Meyer E, Beyersmann J, Bertz H et al (2007) Risk factor analysis of blood stream infection and pneumonia in neutropenic patients after peripheral blood stem-cell transplantation. Bone Marrow Transplant 39(3):173–178PubMedCrossRef Meyer E, Beyersmann J, Bertz H et al (2007) Risk factor analysis of blood stream infection and pneumonia in neutropenic patients after peripheral blood stem-cell transplantation. Bone Marrow Transplant 39(3):173–178PubMedCrossRef
16.
go back to reference [No authors listed]. EORTC International Antimicrobial Therapy Cooperative Group. Gram-positive bacteraemia in granulocytopenic cancer patients. European Journal of Cancer 1990; 26:569–74 [No authors listed]. EORTC International Antimicrobial Therapy Cooperative Group. Gram-positive bacteraemia in granulocytopenic cancer patients. European Journal of Cancer 1990; 26:569–74
17.
go back to reference Hann I, Viscoli C, Paesmans M, Gaya H, Glauser M (1997) A comparison of outcome from febrile neutropenic episodes in children compared with adults: results from four EORTC studies. International Antimicrobial Therapy Cooperative Group (IATCG) of the European Organization for Research and Treatment of Cancer (EORTC). Br J Haematol 99:580–588PubMedCrossRef Hann I, Viscoli C, Paesmans M, Gaya H, Glauser M (1997) A comparison of outcome from febrile neutropenic episodes in children compared with adults: results from four EORTC studies. International Antimicrobial Therapy Cooperative Group (IATCG) of the European Organization for Research and Treatment of Cancer (EORTC). Br J Haematol 99:580–588PubMedCrossRef
18.
go back to reference Bucaneve G, Micozzi A, Menichetti F et al (2005) Levofloxacin to prevent bacterial infection in patients with cancer and neutropenia. N Engl J Med 353:977–987PubMedCrossRef Bucaneve G, Micozzi A, Menichetti F et al (2005) Levofloxacin to prevent bacterial infection in patients with cancer and neutropenia. N Engl J Med 353:977–987PubMedCrossRef
19.
go back to reference Nørgaard M, Larsson H, Pedersen G, Schønheyder HC, Sørensen HT (2006) Risk of bacteraemia and mortality in patients with haematological malignancies. Clin Microbiol Infect 12(3):217–223PubMedCrossRef Nørgaard M, Larsson H, Pedersen G, Schønheyder HC, Sørensen HT (2006) Risk of bacteraemia and mortality in patients with haematological malignancies. Clin Microbiol Infect 12(3):217–223PubMedCrossRef
20.
go back to reference Tumbarello M, Spanu T, Caira M et al (2009) Factors associated with mortality in bacteremic patients with hematologic malignancies. Diagn Microbiol Infect Dis 64:320–326PubMedCrossRef Tumbarello M, Spanu T, Caira M et al (2009) Factors associated with mortality in bacteremic patients with hematologic malignancies. Diagn Microbiol Infect Dis 64:320–326PubMedCrossRef
21.
go back to reference Trecarichi EM, Tumbarello M, Spanu T et al (2009) Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies. J Infect 58:299–307PubMedCrossRef Trecarichi EM, Tumbarello M, Spanu T et al (2009) Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies. J Infect 58:299–307PubMedCrossRef
22.
go back to reference des Champs-Bro B, Leroy-Cotteau A, Mazingue F et al (2011) Invasive fungal infections: epidemiology and analysis of antifungal prescriptions in onco-haematology. J Clin Pharm Ther 36(2):152–160PubMedCrossRef des Champs-Bro B, Leroy-Cotteau A, Mazingue F et al (2011) Invasive fungal infections: epidemiology and analysis of antifungal prescriptions in onco-haematology. J Clin Pharm Ther 36(2):152–160PubMedCrossRef
24.
go back to reference Nucci M, Gloria AB, Silla L et al, Prospective surveillance study of invasive fungal infection in hemopoietic stem cell transplant recipients and in patients with acute myeloid leukemia. 51th ICAAC, Chicago (USA) 16–20 September 2011, M-1508 Nucci M, Gloria AB, Silla L et al, Prospective surveillance study of invasive fungal infection in hemopoietic stem cell transplant recipients and in patients with acute myeloid leukemia. 51th ICAAC, Chicago (USA) 16–20 September 2011, M-1508
25.
go back to reference Pagano L, Caira M, Picardi M et al (2007) Invasive aspergillosis in patients with acute leukemia: update on morbidity and mortality—SEIFEM-C Report. Clin Infect Dis 44:1524–1525PubMedCrossRef Pagano L, Caira M, Picardi M et al (2007) Invasive aspergillosis in patients with acute leukemia: update on morbidity and mortality—SEIFEM-C Report. Clin Infect Dis 44:1524–1525PubMedCrossRef
26.
go back to reference Lin SJ, Schranz J, Teutsch SM (2001) Aspergillosis case-fatality rate: systematic review of the literature. Clin Infect Dis 32:358–366PubMedCrossRef Lin SJ, Schranz J, Teutsch SM (2001) Aspergillosis case-fatality rate: systematic review of the literature. Clin Infect Dis 32:358–366PubMedCrossRef
Metadata
Title
A prospective survey of febrile events in hematological malignancies
Authors
L. Pagano
M. Caira
G. Rossi
M. Tumbarello
R. Fanci
M. G. Garzia
N. Vianelli
N. Filardi
P. De Fabritiis
A. Beltrame
M. Musso
A. Piccin
A. Cuneo
C. Cattaneo
T. Aloisi
M. Riva
G. Rossi
U. Salvadori
M. Brugiatelli
S. Sannicolò
M. Morselli
A. Bonini
P. Viale
A. Nosari
F. Aversa
for the Hema e-Chart Group, Italy
Publication date
01-05-2012
Publisher
Springer-Verlag
Published in
Annals of Hematology / Issue 5/2012
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-011-1373-2

Other articles of this Issue 5/2012

Annals of Hematology 5/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.